Quick Takeaways
- Sio Capital Management, LLC filed SCHEDULE 13G for Bright Minds Biosciences Inc. Common Shares (DRUG).
- Disclosed ownership: 7.2%.
- Date of event: 31 Mar 2025.
Sio Capital Management, LLC - 31 Mar 2025 SCHEDULE 13G Report for Bright Minds Biosciences Inc. Common Shares (DRUG)
- Filing Manager
- Sio Capital Management, LLC
- Reporting Manager
- Sio Capital Management, LLC
- Symbol
- DRUG
- Shares outstanding
- 7,039,695 shares
- Disclosed Ownership
- 507,562 shares
- Ownership
- 7.2%
- Form type
- SCHEDULE 13G
- Filing time
- 08 Apr 2025, 15:14:41 UTC
- Date of event
- 31 Mar 2025
- Previous filing
- 10 Feb 2025
- Next filing
- 13 Aug 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"Sio Capital Management, LLC disclosed 7.2% ownership in Bright Minds Biosciences Inc. Common Shares (DRUG) on 31 Mar 2025."
What Changed
- Previous schedule filing date: 10 Feb 2025.
- Current filing was accepted on 08 Apr 2025, 15:14.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Sio Capital Management, LLC | 7.2% | 507,562 | 0 | 507,562 | /s/ Jin W. Lee | Chief Compliance Officer |